DDX53 and neoplasm: Since ANO1 knockdown could revoke the immune‐suppressive tumor microenvironment, we evaluated the impact of inhibiting ANO1 on the effectiveness of anti‐PD‐1 antibody in MC38‐ or CT26‐engrafted C57BL‐6J/BALB‐C mice models.